Literature DB >> 19224114

Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations.

Anwar Mechri1, Marie-Chantal Bourdel, Héla Slama, David Gourion, Lotfi Gaha, Marie-Odile Krebs.   

Abstract

Recent studies have suggested that ethnicity and socioeconomic status may have an impact on the frequency and significance of neurological soft signs (NSS). However, this impact has not been adequately assessed. The objectives were to determine the NSS scores in patients with schizophrenia and their unaffected siblings and to examine the clinical and therapeutic correlates of NSS in two ethnic and socioeconomic distinct populations. Two independent replicate studies were carried out: (1) a French Caucasian sample of 69 patients with schizophrenia, 43 of their unaffected siblings and 108 control subjects; (2) a Tunisian sample of 66 patients with schizophrenia, 31 of their unaffected siblings and 60 control subjects. NSS were assessed with a multidimensional scale, previously validated in drug-naïve and treated samples of patients with schizophrenia. Both patient groups were assessed with the positive and negative syndrome scale (PANSS), the clinical global impressions (CGI) and the global assessment of functioning. NSS total scores were significantly higher in patients with schizophrenia comparatively to siblings and to controls in both studies. The two sibling groups had also higher NSS scores than controls. In addition, NSS total scores were correlated to the PANSS negative and disorganization sub-scores, to the CGI-severity of illness and to a low educational level in both studies. These studies provide a confirmation in two distinct samples of the high prevalence of NSS in patients with schizophrenia, and in their biological relatives, independently of their respective ethnic and socioeconomic origins.

Entities:  

Mesh:

Year:  2009        PMID: 19224114     DOI: 10.1007/s00406-008-0859-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  41 in total

1.  Neurological signs and the heterogeneity of schizophrenia.

Authors:  C Arango; B Kirkpatrick; R W Buchanan
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

2.  The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia.

Authors:  R W Buchanan; D W Heinrichs
Journal:  Psychiatry Res       Date:  1989-03       Impact factor: 3.222

3.  Neurological soft signs in first-episode schizophrenia: a follow-up study.

Authors:  Silke Bachmann; Christina Bottmer; Johannes Schröder
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

4.  Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates.

Authors:  Robin Emsley; H Jadri Turner; Piet P Oosthuizen; Jonathan Carr
Journal:  Schizophr Res       Date:  2005-06-01       Impact factor: 4.939

5.  Neurological abnormalities in familial and sporadic schizophrenia.

Authors:  T D Griffiths; T Sigmundsson; N Takei; D Rowe; R M Murray
Journal:  Brain       Date:  1998-02       Impact factor: 13.501

6.  Neurological abnormalities in schizophrenic patients and their siblings.

Authors:  B Ismail; E Cantor-Graae; T F McNeil
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

7.  Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.

Authors:  Alex Hofer; Maria A Rettenbacher; Christian G Widschwendter; Georg Kemmler; Martina Hummer; W Wolfgang Fleischhacker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-29       Impact factor: 5.270

8.  Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype.

Authors:  D Gourion; C Goldberger; J P Olie; H Lôo; M O Krebs
Journal:  Schizophr Res       Date:  2004-03-01       Impact factor: 4.939

9.  [Neurological soft signs in schizophrenic patients and their nonaffected siblings].

Authors:  A Mechri; H Slama; M-C Bourdel; S Chebel; O Mandhouj; M-O Krebs; L Gaha
Journal:  Encephale       Date:  2008-01-11       Impact factor: 1.291

10.  Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.

Authors:  R Kaiser; P-B Tremblay; F Klufmöller; I Roots; J Brockmöller
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

View more
  12 in total

1.  Twin-based study of the complex interplay between childhood maltreatment, socioeconomic status and adult memory.

Authors:  Ximena Goldberg; Silvia Alemany; Mar Fatjó-Vilas; Itxaso González-Ortega; Ana González-Pinto; Manuel J Cuesta; Lourdes Fañanás
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-28       Impact factor: 5.270

2.  Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development.

Authors:  Olivier Gay; Marion Plaze; Catherine Oppenheim; Raphael Gaillard; Jean-Pierre Olié; Marie-Odile Krebs; Arnaud Cachia
Journal:  J Psychiatry Neurosci       Date:  2017-03       Impact factor: 6.186

3.  Perinatal complications in unaffected sisters of anorexia nervosa patients: testing a covariation model between genetic and environmental factors.

Authors:  Angela Favaro; Elena Tenconi; Romina Bosello; Daniela Degortes; Paolo Santonastaso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-31       Impact factor: 5.270

4.  Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.

Authors:  Philip Awadalla; Julie Gauthier; Rachel A Myers; Ferran Casals; Fadi F Hamdan; Alexander R Griffing; Mélanie Côté; Edouard Henrion; Dan Spiegelman; Julien Tarabeux; Amélie Piton; Yan Yang; Adam Boyko; Carlos Bustamante; Lan Xiong; Judith L Rapoport; Anjené M Addington; J Lynn E DeLisi; Marie-Odile Krebs; Ridha Joober; Bruno Millet; Eric Fombonne; Laurent Mottron; Martine Zilversmit; Jon Keebler; Hussein Daoud; Claude Marineau; Marie-Hélène Roy-Gagnon; Marie-Pierre Dubé; Adam Eyre-Walker; Pierre Drapeau; Eric A Stone; Ronald G Lafrenière; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2010-09-10       Impact factor: 11.025

5.  Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States.

Authors:  Neil Krishan Aggarwal; Xiang Yang Zhang; Elina Stefanovics; Da Chun Chen; Mei Hong Xiu; Ke Xu; Robert A Rosenheck
Journal:  J Nerv Ment Dis       Date:  2012-09       Impact factor: 2.254

Review 6.  Schizophrenia: a systemic disorder.

Authors:  Brian Kirkpatrick; Brian Miller; Clemente García-Rizo; Emilio Fernandez-Egea
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-07

7.  A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia.

Authors:  Kishen Neelam; Deepak Garg; Max Marshall
Journal:  BMC Psychiatry       Date:  2011-08-22       Impact factor: 3.630

8.  Sensory and motor secondary symptoms as indicators of brain vulnerability.

Authors:  Nava Levit-Binnun; Michael Davidovitch; Yulia Golland
Journal:  J Neurodev Disord       Date:  2013-09-24       Impact factor: 4.025

9.  Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives.

Authors:  Liliana Galindo; Francisco Pastoriza; Daniel Bergé; Anna Mané; Marisol Picado; Antonio Bulbena; Patricia Robledo; Victor Pérez; Oscar Vilarroya; Claude Robert Cloninger
Journal:  PeerJ       Date:  2016-04-26       Impact factor: 2.984

10.  Combined visual and motor disorganization in patients with schizophrenia.

Authors:  Anne Giersch; Hélène Wilquin; Rémi L Capa; Yvonne N Delevoye-Turrell
Journal:  Front Psychol       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.